导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.51% | 3060/4982 |
| 近一周 | -2.09% | 3327/5419 |
| 近一月 | -0.62% | 1096/5423 |
| 近一季 | 1.17% | 973/5376 |
| 近半年 | -8.30% | 3487/5131 |
| 近一年 | - | 2759/4741 |
| 近两年 | 21.31% | 3569/4208 |
| 近三年 | -14.88% | 3410/3661 |
| 成立以来 | 55.12% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.20% 1118/5130 |
-11.15% 4542/5464 |
- - |
- - |
| 2025 | 6.64% 4139/5130 |
-3.60% 4377/4624 |
-0.38% 3382/4802 |
9.41% 4078/4970 |
1.49% 1444/5130 |
| 2024 | -10.41% 3642/4618 |
-17.69% 4139/4340 |
1.71% 911/4442 |
11.16% 1901/4550 |
-3.73% 2722/4618 |
| 2023 | -20.13% 2670/4216 |
2.97% 1486/3759 |
-8.14% 3013/3909 |
-6.49% 1711/4055 |
-9.70% 3687/4209 |
| 2022 | -31.57% 2437/3578 |
-18.11% 1532/2804 |
4.52% 2136/3205 |
-11.61% 1451/3430 |
-9.55% 3200/3570 |
| 2021 | -4.86% 1219/2717 |
-7.56% 1272/1745 |
10.37% 958/2232 |
-6.44% 1371/2560 |
-0.32% 1602/2708 |
| 2020 | 36.24% 780/1596 |
-8.67% 906/1036 |
16.22% 846/1256 |
10.20% 645/1472 |
16.47% 524/1690 |
| 2019 | 32.81% 519/926 |
22.01% 1218/3054 |
-1.34% 1830/3201 |
2.65% 662/939 |
7.49% 598/1014 |
| 2018 | -24.62% 296/668 |
- - |
- - |
- - |
-11.43% 2245/2977 |
| 2017 | 6.32% 322/531 |
- - |
- - |
- - |
- - |
| 2016 | -6.88% 106/455 |
- - |
- - |
- - |
- - |
| 2015 | 33.46% 285/433 |
- - |
- - |
- - |
- - |
| 2014 | 55.31% 21/432 |
- - |
- - |
- - |
- - |
| 2013 | 4.29% 315/398 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 大摩量化配置混合A VS. 长安宏观策略混合A(740001) |